Union Minister Piyush Goyal met with Indian pharmaceutical stakeholders to boost industry growth and refine regulations. Discussions centered on innovation, data protection, and scaling manufacturing. Despite US tariff threats on patented drugs, India’s generic drug exports, a major market share, are expected to remain largely unaffected, showcasing the sector’s resilience and government support for future growth.